Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Source:http://linkedlifedata.com/resource/pubmed/id/17917671

Download in:

View as

General Info

PMID
17917671